Gilead’s Revenue Is Accelerating, But are its Acquisitions Worth the Cost?

Reported by Yahoo Finance · Published 24 Aug 2026, 3:57 AM MYT (2 hr ago)

Summary

Source & full coverage: this summary is aggregated from Yahoo Finance, the original publisher. Read the complete report for full context, data and quotes.

Read the original report at Yahoo Finance →

Most Recent

If a Bear Market Is Coming, Here's What All of the Smartest Investors Are Doing Right Now 1 hr ago UBS revamps S&P 500 target for rest of 2026 1 hr ago Better Dividend King to Buy Right Now: Abbott Labs or Johnson & Johnson? 1 hr ago Oracle vs. Amazon: Which Is the Better AI Cloud Stock to Own for the Next 5 Years? 1 hr ago $22 Billion in Customer Deposits Did Not Stop This Chip CEO From Selling $37 Million 1 hr ago Billionaire Druckenmiller makes cancer stock his #1 buy for a reason 1 hr ago

EconPulse

Markets. Economy. Malaysia & The World.

Independent economic news aggregation for Malaysia, Asia and global markets, updated throughout the day.

Company

About Us Editorial Standards & Corrections Privacy Policy

Work With Us

Submit a Press Release Partnerships & Advertising Contact Us RSS Feed

Contact

editor@econpulse.my

Editorial & newsroom enquiries answered within 1–2 business days.

Gilead’s Revenue Is Accelerating, But are its Acquisitions Worth the Cost?

Summary

More in Markets

If a Bear Market Is Coming, Here's What All of the Smartest Investors Are Doing Right Now

UBS revamps S&P 500 target for rest of 2026

Better Dividend King to Buy Right Now: Abbott Labs or Johnson & Johnson?

Oracle vs. Amazon: Which Is the Better AI Cloud Stock to Own for the Next 5 Years?

$22 Billion in Customer Deposits Did Not Stop This Chip CEO From Selling $37 Million

Billionaire Druckenmiller makes cancer stock his #1 buy for a reason